Shengren Cen

405 total citations
8 papers, 284 citations indexed

About

Shengren Cen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Shengren Cen has authored 8 papers receiving a total of 284 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Cancer Research. Recurrent topics in Shengren Cen's work include Circular RNAs in diseases (3 papers), Ferroptosis and cancer prognosis (3 papers) and RNA regulation and disease (2 papers). Shengren Cen is often cited by papers focused on Circular RNAs in diseases (3 papers), Ferroptosis and cancer prognosis (3 papers) and RNA regulation and disease (2 papers). Shengren Cen collaborates with scholars based in China. Shengren Cen's co-authors include Taowei Yang, Xumin Zhou, Wenbin Chen, Libin Zou, Junqi Luo, Kaihui Wu, Fangpeng Shu, Daojun Lv, Xiangming Mao and Yang Yu and has published in prestigious journals such as Cell Death and Disease, Pharmacological Research and Cell Cycle.

In The Last Decade

Shengren Cen

8 papers receiving 280 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shengren Cen China 6 202 160 119 43 26 8 284
Libin Zou China 7 233 1.2× 192 1.2× 122 1.0× 47 1.1× 30 1.2× 12 324
Le Tang China 7 186 0.9× 190 1.2× 60 0.5× 66 1.5× 21 0.8× 14 285
Junqi Luo China 8 255 1.3× 218 1.4× 125 1.1× 45 1.0× 32 1.2× 9 360
Anqi Dong China 5 173 0.9× 127 0.8× 154 1.3× 32 0.7× 18 0.7× 8 245
Xiaonan Sheng China 10 201 1.0× 193 1.2× 137 1.2× 51 1.2× 38 1.5× 22 332
Aryn M. Rowsam United States 4 175 0.9× 117 0.7× 85 0.7× 44 1.0× 22 0.8× 5 272
Changjiang Yang China 9 182 0.9× 102 0.6× 52 0.4× 73 1.7× 35 1.3× 15 283
Mingdian Lu China 9 198 1.0× 101 0.6× 50 0.4× 45 1.0× 26 1.0× 15 271
Mingdong Liu China 7 203 1.0× 126 0.8× 98 0.8× 63 1.5× 23 0.9× 7 266
Qian Dong China 7 217 1.1× 221 1.4× 44 0.4× 31 0.7× 18 0.7× 14 291

Countries citing papers authored by Shengren Cen

Since Specialization
Citations

This map shows the geographic impact of Shengren Cen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shengren Cen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shengren Cen more than expected).

Fields of papers citing papers by Shengren Cen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shengren Cen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shengren Cen. The network helps show where Shengren Cen may publish in the future.

Co-authorship network of co-authors of Shengren Cen

This figure shows the co-authorship network connecting the top 25 collaborators of Shengren Cen. A scholar is included among the top collaborators of Shengren Cen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shengren Cen. Shengren Cen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Luo, Junqi, Taowei Yang, Jun Wu, et al.. (2023). Exosomal PGAM1 promotes prostate cancer angiogenesis and metastasis by interacting with ACTG1. Cell Death and Disease. 14(8). 40 indexed citations
2.
Cen, Shengren, et al.. (2023). Comprehensive analysis of the biological functions of endoplasmic reticulum stress in prostate cancer. Frontiers in Endocrinology. 14. 1090277–1090277. 2 indexed citations
3.
Lv, Daojun, Shengren Cen, Shuxin Yang, et al.. (2023). Hsa_circ_0063329 inhibits prostate cancer growth and metastasis by modulating the miR-605-5p/tgif2 axis. Cell Cycle. 22(9). 1101–1115. 12 indexed citations
4.
Chen, Wenbin, Zhao Zhang, Shengren Cen, et al.. (2023). Exposure to elevated temperature affects the expression of PIWI‐interacting RNAs and associated transcripts in mouse testes. Andrology. 11(4). 724–737. 5 indexed citations
5.
Zou, Libin, Wenbin Chen, Xumin Zhou, et al.. (2022). N6-methyladenosine demethylase FTO suppressed prostate cancer progression by maintaining CLIC4 mRNA stability. Cell Death Discovery. 8(1). 184–184. 33 indexed citations
6.
Zhou, Xumin, Libin Zou, Hangyu Liao, et al.. (2021). Abrogation of HnRNP L enhances anti-PD-1 therapy efficacy via diminishing PD-L1 and promoting CD8+ T cell-mediated ferroptosis in castration-resistant prostate cancer. Acta Pharmaceutica Sinica B. 12(2). 692–707. 78 indexed citations
7.
Chen, Wenbin, Shengren Cen, Xumin Zhou, et al.. (2021). Circular RNA CircNOLC1, Upregulated by NF-KappaB, Promotes the Progression of Prostate Cancer via miR-647/PAQR4 Axis. Frontiers in Cell and Developmental Biology. 8. 624764–624764. 41 indexed citations
8.
Zhou, Xumin, Libin Zou, Wenbin Chen, et al.. (2020). Flubendazole, FDA-approved anthelmintic, elicits valid antitumor effects by targeting P53 and promoting ferroptosis in castration-resistant prostate cancer. Pharmacological Research. 164. 105305–105305. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026